As defined by the American Society of Reproductive Medicine, recurrent miscarriage or recurrent pregnancy loss is defined as two or more failed pregnancies. (1). There are various causes for RPL and yet, in about 40% of cases, no cause can be identified after extensive investigation. It is believed that inherited and acquired thrombophilia like Protein C/S deficiency and genetic mutations in the Factor V and the Prothrombin gene maybe a cause of RPL (2). There is a significant association between the Prothrombin G2021M mutation (PTG) with RPL which has been shown by numerous other studies (3). The data with respect to PTG G20210A mutations and its association with RPL is scant in Indian population.
PTG20210A mutation is seen in around 2-3% of the Caucasian population with estimated thrombotic risk being very low at 1.5-2.2 (5) . Prothrombin mutation is a functional gain mutation occurring on exon 14 coding for 3' translational end of mRNA resulting in increased levels of Prothrombin.
Studies evaluating the role of Prothrombin gene mutations in cases of RPL have shown conflicting results. As reported in an Iranian study, there was no significant difference between the prevalence of these mutations between the cases versus the controls. (6) . A similar finding was reported by Mierla et al who did not find an association between the PTG20210A mutations with RPL (7). This is in contrast to a Turkish study which found a significant association between the PTG20210A mutation and RPL (8) .
The association between the PTG20210A mutation and RPL likely reflects the prevalence of this mutation in the general population. In Indian populations, the prevalence of the PTG20210A mutation has been evaluated in diseases as diverse as ischemic stroke and hepatic venous outflow tract obstruction, and the reported prevalence of this mutation is low (9) . In a study of 432 patients of venous thromboembolism from western India, Ghosh et al. did not find a single case where there was a prothrombin PTG20210A mutation (10) .
Of the total of 56 cases tested for Prothrombin mutation in the present study, no mutation was detected in RPL group (0/38), while one case was detected to have a heterozygous Prothrombin mutation in the control group (1/18).
We believe that this is the first Indian study which has studied the relationship between the Prothrombin gene mutation and RPL. It is likely that the prevalence of the PTG20210A gene mutation is very low in the Indian population. This low prevalence and its virtual absence in cases of RPL indicate that Prothrombin gene mutations are very unlikely to be a cause for RPL in the Indian population. It is suggested that an evaluation of the PTG is not required in cases of RPL in the Indian population.
